SUPERNUS PHARMACEUTICALS, INC. Annual Interest Expense in USD from 2011 to 2021

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
Supernus Pharmaceuticals, Inc. quarterly/annual Interest Expense history and growth rate from 2011 to 2021.
  • Supernus Pharmaceuticals, Inc. Interest Expense for the quarter ending March 31, 2024 was $0.000, a 100% decline year-over-year.
  • Supernus Pharmaceuticals, Inc. annual Interest Expense for 2021 was $19.7M, a 1.34% increase from 2020.
  • Supernus Pharmaceuticals, Inc. annual Interest Expense for 2020 was $19.4M, a 6.75% increase from 2019.
  • Supernus Pharmaceuticals, Inc. annual Interest Expense for 2019 was $18.2M, a 31.6% increase from 2018.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Annual (USD)
Interest Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2021 $19.7M +$261K +1.34% Jan 1, 2021 Dec 31, 2021 10-K 2022-04-13
2020 $19.4M +$1.23M +6.75% Jan 1, 2020 Dec 31, 2020 10-K 2022-04-13
2019 $18.2M +$4.37M +31.6% Jan 1, 2019 Dec 31, 2019 10-K 2022-04-13
2018 $13.8M +$13.7M +10228% Jan 1, 2018 Dec 31, 2018 10-K 2021-03-08
2017 $134K -$409K -75.3% Jan 1, 2017 Dec 31, 2017 10-K 2020-02-28
2016 $543K -$686K -55.8% Jan 1, 2016 Dec 31, 2016 10-K 2019-03-01
2015 $1.23M -$3.73M -75.2% Jan 1, 2015 Dec 31, 2015 10-K 2018-03-01
2014 $4.96M -$2.89M -36.8% Jan 1, 2014 Dec 31, 2014 10-K 2017-03-16
2013 $7.85M +$4.27M +120% Jan 1, 2013 Dec 31, 2013 10-K/A 2017-01-20
2012 $3.58M +$1.71M +91.6% Jan 1, 2012 Dec 31, 2012 10-K 2015-03-12
2011 $1.87M Jan 1, 2011 Dec 31, 2011 10-K 2014-03-21
* An asterisk sign (*) next to the value indicates that the value is likely invalid.